Implementation of deep learning artificial intelligence in vision-threatening disease screenings for an underserved community during COVID-19.

Journal: Journal of telemedicine and telecare
PMID:

Abstract

INTRODUCTION: Age-related macular degeneration, diabetic retinopathy, and glaucoma are vision-threatening diseases that are leading causes of vision loss. Many studies have validated deep learning artificial intelligence for image-based diagnosis of vision-threatening diseases. Our study prospectively investigated deep learning artificial intelligence applications in student-run non-mydriatic screenings for an underserved, primarily Hispanic community during COVID-19.

Authors

  • Aretha Zhu
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Priya Tailor
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Rashika Verma
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Isis Zhang
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Brian Schott
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Catherine Ye
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Bernard Szirth
    Rutgers New Jersey Medical School, Newark, NJ.
  • Miriam Habiel
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Albert S Khouri
    Rutgers New Jersey Medical School, Newark, NJ.